Cite

    Mukund, A. et al. (2022). Response evaluation of locoregional therapies in combined hepatocellular–cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study. Clinical radiology. 77 (2), pp. 121-129. [Online].